In a recent study published on the medRxiv* preprint server, researchers validate a quick, highly efficient, and automated assay to detect neutralizing antibodies (nAb) against the severe acute ...
Biomedical research faces a ubiquitous and fundamental challenge: Because the goal of the research is to improve human health, the human body is logically the best place to perform experiments.
Creating a clear and well-defined bioanalytical methodology to quantify humoral and cellular immune responses is critical for ...
The assays allow scientists to measure neutralizing antibodies quickly and efficiently against wild-type and significant variants of SARS-CoV-2 virus. Scientists developing vaccines and therapeutics ...
The highly transmissible omicron (B.1.1.529) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is of mounting concern globally. The omicron variant carries a large number of ...
On November 26, 2021, the World Health Organization (WHO) named the B.1.1.529 (omicron) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first detected in South Africa, as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results